FDA Approves Janssen’s NUCYNTA ER for Diabetic Peripheral Neuropathy Pain

The U.S. FDA has approved the supplemental New Drug Application (sNDA), submitted by Janssen Pharmaceuticals, for NUCYNTA ER (tapentadol) extended-release tablets. NUCYNTA ER is an oral analgesic taken twice daily, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Read more

Talking About Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy (DPN) is nerve damage that affects the feet, legs, arms and hands. It’s a potential complication of diabetes, and it’s a frightening one which most people know very little about. People experience DPN in a variety of ways. They may feel burning, shooting pain… Read more

Subscribe to our Newsletter

Hide me